Stimulation of eryptosis by anti-A IgG antibodies

Cellular Physiology and Biochemistry

Volumn 20, Issue 5, 2007, Pages 591-600

  Attanasio, Philipp ^a   Shumilina, Ekaterina ^a   Hermle, Tobias ^a   Kiedaisch, Valentin ^a   Lang, Philipp A ^a   Huber, Stephan M ^a   Wieder, Thomas ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Calcium; Cell volume; Gardos channel; Phosphatidylserine

Indexed keywords

BLOOD GROUP A ANTIBODY; CATION CHANNEL; FLUO 3; IMMUNOGLOBULIN G ANTIBODY; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

ARTICLE; BLOOD GROUP A; BLOOD GROUP O; CELL STIMULATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; NORMAL HUMAN; OSMOTIC STRESS; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 34548367512     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107542     Document Type: Article

References (69)

1. Dekkers DW, Comfurius P, Bevers EM, Zwaal RF: Comparison between Ca2+-induced scrambling of various fluorescently labelled lipid analogues in red blood cells. Biochem J 2002;362:741-747.
2. Woon LA, Holland JW, Kable EP, Roufogalis BD: Ca2+ sensitivity of phospholipid scrambling in human red cell ghosts. Cell Calcium 1999;25:313-320.
3. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF, Schulze-Osthoff K, Wesselborg S: Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-1206.
4. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM, Lang F: Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 2003;13:347-356.
5. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C, Huart JJ, Montreuil J, Ameisen JC: Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001;8:1143-1156.
6. Daugas E, Cande C, Kroemer G: Erythrocytes: death of a mummy. Cell Death Differ 2001;8:1131-1133.
7. Lang PA, Warskulat U, Heller-Stilb B, Huang DY, Grenz A, Myssina S, Duszenko M, Lang F, Haussinger D, Vallon V, Wieder T: Blunted apoptosis of erythrocytes from taurine transporter deficient mice. Cell Physiol Biochem 2003;13:337-346.
8. Duranton C, Huber SM, Lang F: Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J Physiol 2002;539:847-855.
9. Duranton C, Huber S, Tanneur V, Lang K, Brand V, Sandu C, Lang F: Electrophysiological properties of the Plasmodium Falciparum-induced cation conductance of human erythrocytes. Cell Physiol Biochem 2003;13:189-198.
10. Huber SM, Gamper N, Lang F: Chloride conductance and volume-regulatory non-selective cation conductance in human red blood cell ghosts. Pflugers Arch 2001;441:551-558.
11. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM: Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-256.
12. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, Wieder T: Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 2004;11:231-243.
13. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000;405:85-90.
14. Henson PM, Bratton DL, Fadok VA: The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2001;2:627-633.
15. Messmer UK, Pfeilschifter J: New insights into the mechanism for clearance of apoptotic cells. Bioessays 2000;22:878-881.
16. Boas FE, Forman L, Beutler E: Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A 1998;95:3077-3081.
17. Eda S, Sherman IW: Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cell Physiol Biochem 2002;12:373-384.
18. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L, Fritz J, Lang F, Huber SM, Wieder T: Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 2002;12:365-372.
19. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C, Nammi S, Henke G, Myssina S, Krikov M, Huber SM, Wieder T, Lang F: Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004;448:471-477.
20. Kempe DS, Lang PA, Eisele K, Klarl BA, Wieder T, Huber SM, Duranton C, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by lead ions. Am J Physiol Cell Physiol 2005;288:C396-C402.
21. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B, Risler T, Baur M, Olbricht CJ, Zimmerhackl LB, Zipfel PF, Wieder T, Lang F: Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006;84:378-388.
22. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, Friedrich B, Dreischer P, Wolz C, Schumacher U, Peschel A, Gotz F, Doring G, Wieder T, Gulbins E, Lang F: Suicidal erythrocyte death in sepsis. J Mol Med 2006;
23. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rubben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Haussinger D, Gulbins E, Lang F: Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007;13:164-170.
24. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G, Jr., Thornalley PJ, Schleicher E, Wieder T, Lang F: Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 2006;18:223-232.
25. Nicolay JP, Gatz S, Liebig G, Gulbins E, Lang F: Amyloid induced suicidal erythrocyte death. Cell Physiol Biochem 2007;19:175-184.
26. Lang PA, Huober J, Bachmann C, Kempe DS, Sobiesiak M, Akel A, Niemoeller OM, Dreischer P, Eisele K, Klarl BA, Gulbins E, Lang F, Wieder T: Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. Cell Physiol Biochem 2006;18:151-164.
27. Akel A, Hermle T, Niemoeller OM, Kempe DS, Lang PA, Attanasio P, Podolski M, Wieder T, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by chlorpromazine. Eur J Pharmacol 2006;532:11-17.
28. Niemoeller OM, Akel A, Lang PA, Attanasio P, Kempe DS, Hermle T, Sobiesiak M, Wieder T, Lang F: Induction of eryptosis by cyclosporine. Naunyn Schmiedebergs Arch Pharmacol 2006;374:41-49.
29. Niemoeller OM, Bentzen PJ, Lang E, Lang F: Adenosine protects against suicidal erythrocyte death. Pflugers Arch 2007;
30. Eisele K, Lang PA, Kempe DS, Klarl BA, Niemoller O, Wieder T, Huber SM, Duranton C, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by mercury ions. Toxicol Appl Pharmacol 2005;
31. Bookchin RM, Ortiz OE, Lew VL: Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 1987;240:193-200.
32. Brugnara C, de Franceschi L, Alper SL: Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993;92:520-526.
33. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM: Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-C1560.
34. Myssina S, Lang PA, Kempe DS, Kaiser S, Huber SM, Wieder T, Lang F: Cl- channel blockers NPPB and niflumic acid blunt Ca(2+)-induced erythrocyte 'apoptosis'. Cell Physiol Biochem 2004;14:241-248.
35. Bortner CD, Hughes FM, Jr., Cidlowski JA: A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem 1997;272:32436-32442.
36. Bortner CD, Cidlowski JA: A necessary role for cell shrinkage in apoptosis. Biochem Pharmacol 1998;56:1549-59.
37. Gomez-Angelats M, Bortner CD, Cidlowski JA: Protein kinase C (PKC) inhibits fas receptor-induced apoptosis through modulation of the loss of K+ and cell shrinkage. A role for PKC upstream of caspases. J Biol Chem 2000;275:19609-19619.
38. Hughes FM, Jr., Bortner CD, Purdy GD, Cidlowski JA: Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem 1997;272:30567-30576.
39. Hughes FM, Jr., Cidlowski JA: Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. Adv Enzyme Regul 1999;39:157-171.
40. Montague JW, Bortner CD, Hughes FM, Jr., Cidlowski JA: A necessary role for reduced intracellular potassium during the DNA degradation phase of apoptosis. Steroids 1999;64:563-569.
41. Perez GI, Maravei DV, Trbovich AM, Cidlowski JA, Tilly JL, Hughes FM, Jr.: Identification of potassium-dependent and -independent components of the apoptotic machinery in mouse ovarian germ cells and granulosa cells. Biol Reprod 2000;63:1358-1369.
42. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, Lang F: Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005;15:195-202.
43. Barvitenko NN, Adragna NC, Weber RE: Erythrocyte signal transduction pathways, their oxygenation dependence and functional significance. Cell Physiol Biochem 2005;15:1-18.
44. Bosman GJ, Willekens FL, Werre JM: Erythrocyte aging: a more than superficial resemblance to apoptosis? Cell Physiol Biochem 2005;16:1-8.
45. Rice L, Alfrey CP: The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 2005;15:245-250.
46. Schwarzer E, Kühn H, Valente E, Arese P: Band 3/COMPLEMENT-mediated Recognition and Removal of Normally Senescent and Pathological Human Erythrocytes. Cell Physiol Biochem 2005;16:133-146.
47. Spalter SH, Kaveri SV, Bonnin E, Mani JC, Cartron JP, Kazatchkine MD: Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens. Blood 1999;93:4418-4424.
48. Hillyer CD, Schwenn MR, Fulton DR, Meissner HC, Berkman EM: Autoimmune hemolytic anemia in Kawasaki disease: a case report. Transfusion 1990;30:738-740.
49. Buckner CD, Clift RA, Sanders JE, Williams B, Gray M, Storb R, Thomas ED: ABO-incompatible marrow transplants. Transplantation 1978;26:233-238.
50. Hazlehurst GR, Brenner MK, Wimperis JZ, Knowles SM, Prentice HG: Haemolysis after T-cell depleted bone marrow transplantation involving minor AB0 incompatibility. Scand J Haematol 1986;37:1-3.
51. Josephson CD, Mullis NC, Van Demark C, Hillyer CD: Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy. Transfusion 2004;44:805-808.
52. Kunimasa J, Yurugi K, Ito K, Yamaoka Y, Uemoto S, Tanaka K, Yoshida H, Maruya E, Saji H, Yokoyama S: Hemolytic reaction due to graft-versus-host (GVH) antibody production after liver transplantation from living donors: report of two cases. Surg Today 1998;28:857-861.
53. Leikola J, Perkins HA: Red cell antibodies and low ionic strength: a study with enzyme-linked antiglobulin test. Transfusion 1980;20:224-228.
54. Lopez A, de la RJ, Arriaga F, Jimenez C, Sanz GF, Carpio N, Marty ML: Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998;38:247-251.
55. Merry AH, Thomson EE, Rawlinson VI, Stratton F: Quantitation of IgG on Erythrocytes: correlation of number of IgG molecules per cell with the strength of the direct and indirect antiglobulin tests. Vox Sang 1984;47:73-81.
56. Sano Y, Date H, Nagahiro I, Aoe M, Shimizu N: Relationship between anti-ABO antibody production and hemolytic anemia after minor ABO-mismatched living-donor lobar lung transplantation. Transplant Proc 2005;37:1371-1372.
57. Sokol RJ, Stamps R, Booker DJ, Scott FM, Laidlaw ST, Vandenberghe EA, Barker HF: Posttransplant immune-mediated hemolysis. Transfusion 2002;42:198-204.
58. Yazdanbakhsh K, Kang S, Tamasauskas D, Sung D, Scaradavou A: Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy. Blood 2003;101:5046-5052.
59. Engelmann B, Schumacher U, Duhm J: Role of ABH blood group antigens in the stimulation of a DIDS-sensitive Ca2+ influx pathway in human erythrocytes by Ulex europaeus agglutinin I and a monoclonal anti A1 antibody. Biochim Biophys Acta 1991;1091:261-269.
60. Lang PA, Kempe DS, Tanneur V, Eisele K, Klarl BA, Myssina S, Jendrossek V, Ishii S, Shimizu T, Waidmann M, Hessler G, Huber SM, Lang F, Wieder T: Stimulation of erythrocyte ceramide formation by platelet-activating factor. J Cell Sci 2005;118:1233-1243.
61. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM: Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990;265:4923-4928.
62. Barry PH, Lynch JW: Liquid junction potentials and small cell effects in patch-clamp analysis. J Membr Biol 1991;121:101-117.
63. Engelmann B, Gross V, Schumacher U, Duhm J: Epidermal growth factor stimulates Ca2+ uptake of human erythrocytes. Pflugers Arch 1992;421:497-502.
64. Head DJ, Lee ZE, Swallah MM, Avent ND: Ligation of CD47 mediates phosphatidylserine expression on erythrocytes and a concomitant loss of viability in vitro. Br J Haematol 2005;130:788-790.
65. Head DJ, Lee ZE, Poole J, Avent ND: Expression of phosphatidylserine (PS) on wild-type and Gerbich variant erythrocytes following glycophorin-C (GPC) ligation. Br J Haematol 2005;129:130-137.
66. Mandal D, Mazumder A, Das P, Kundu M, Basu J: Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J Biol Chem 2005;280:39460-39467.
67. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, Lang F: Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 2003;14:2750-2757.
68. Closse C, Dachary-Prigent J, Boisseau MR: Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-302.
69. Lang F, Busch GL, Ritter M, Völkl H, Waldegger S, Gulbins E, Häussinger D: Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306.